Brooks Pharmacy

Brooks Pharmacy

File:Brooks Pharmacy.svg
Company type	Pharmacy
Founded	1932 (1932)
Defunct	June 4, 2007 (2007-06-04)
Fate	Acquired by Rite Aid
Headquarters	Warwick, Rhode Island, U.S.
Key people	Mary Sammons (president and CEO)
Parent	Revco (1994) Jean Coutu Group (1994–2007)

Brooks Pharmacy operated a network exceeding 330 drugstores across New England and New York, becoming a prominent and trusted brand within the New England pharmaceutical market over several decades. Its corporate headquarters were situated in Warwick, Rhode Island.

At the peak of its success during the late 1990s and early 2000s, Brooks ranked among the leading regional pharmacy chains in the United States, standing as the second largest in New England. It held a particularly strong market position in Vermont, New Hampshire, and Rhode Island. In 2002, Brooks earned the distinction of Regional Chain of the Year at the Rex Awards.

Between 2004 and 2006, Brooks encountered significant challenges as its parent company struggled to successfully merge 1,500 Eckerd stores acquired from J.C. Penney into the existing Brooks framework. This integration failure contributed to a continuous decline in market share and underperformance in same-store sales, while competitors such as CVS and Walgreens expanded their presence and consolidated their foothold in New England. On June 4, 2007, Brooks Pharmacy publicly confirmed the sale of its stores to Rite Aid, marking the retirement of the Brooks brand name that had long been synonymous with New England pharmacy retailing.

Origins

The origins of Brooks Pharmacy can be traced back to the now-defunct family-owned Adams Drug Company based in Pawtucket, Rhode Island, established in 1933 by the Salmanson family. Adams operated numerous outlets under the Brooks Drug name across Vermont and New York, along with other retail brands throughout the Northeastern United States.

Acquisition by Pantry Pride

In 1984, Adams Drug was purchased by Pantry Pride, a supermarket chain headquartered in Florida, for $100 million. This deal encompassed 420 stores spanning ten Northeastern states, with approximately 70% carrying the Brooks brand. The subsequent year saw corporate raider Ronald Perelman orchestrate a takeover of Revlon, resulting in Pantry Pride’s assets—including Adams—being transferred under Revlon's umbrella. By 1986, all Adams outlets were rebranded under the Brooks name. Over time, ownership of Brooks shifted among various subsidiaries controlled by Perelman, including California-based Compact Video.

Acquisition by Hook-SupeRx

In 1988, Perelman transferred ownership of Brooks to the Indianapolis-based drugstore chain Hook-SupeRx. Following this acquisition, Brooks underwent a leadership reshuffle, appointing Gayl W. Doster as Chief Operating Officer, William Welsh as head of operations, and David Morocco overseeing procurement. This new team aimed to revitalize the chain by updating its store network and reversing its decline. By 1991, Brooks introduced the RxWatch system, a pioneering computerized prescription service. The subsequent year, the company launched an aggressive expansion strategy targeting suburban areas of New York City, including the lower Hudson Valley and southwestern Connecticut. By 1993, Brooks operated 77 stores within New York State and had a total of 356 locations overall.

Sale to Revco and Jean Coutu

In 1994, Revco acquired Brooks as part of its broader takeover of Hook-SupeRx. At that time, Brooks' footprint extended from Maine down to Maryland. However, Revco chose not to maintain the Brooks stores situated in New England due to market considerations. Consequently, in the same year, Revco divested 221 Brooks outlets located across Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont, along with the distribution center in Connecticut, selling them to the Quebec-based Jean Coutu Group for $147.5 million. Prior to this transaction, Jean Coutu had already established a presence in Rhode Island and Massachusetts through its U.S. subsidiary operating under the Maxi Drug and Douglas Drug brands.

Revco retained control over 96 Brooks stores in New York and 31 in Pennsylvania, which were later rebranded under the Revco name. Meanwhile, Jean Coutu rebranded its Maxi and Douglas outlets as Brooks; this also became the official trade name for Jean Coutu Group USA. Some former Maxi stores adopted a combined Brooks-Maxi branding approach.

Under Jean Coutu's stewardship, Brooks experienced a period of growth marked by acquisitions of smaller chains and segments of larger ones throughout New England. In 1995, Brooks purchased 30 Rite Aid locations across Massachusetts and Rhode Island while selling 18 stores in Maine back to Rite Aid. After these transactions, Brooks maintained 121 outlets in Massachusetts and 48 in Rhode Island. In 1999, the chain expanded its Vermont presence by acquiring City Drug based in Burlington, adding to its store count in Vermont and re-entering the New York market for the first time since Revco's acquisition in 1994. By 2001, Brooks operated 250 stores across six states. That December, it further expanded by acquiring 80 Osco Drug stores located in Maine, Massachusetts, and New Hampshire from Albertsons.

Merger with Eckerd

Following the Osco acquisition, President Michel Coutu pledged to substantially grow the chain by 2004. This goal was realized in August 2004 when Coutu acquired approximately 1,539 Eckerd Pharmacies along with Eckerd's corporate offices in Largo, Florida from its parent company at the time, J.C. Penney. Shortly after this purchase, Brooks-Eckerd revealed intentions to establish a $30 million headquarters in East Greenwich, Rhode Island.

By 2005, Coutu had consolidated the operations of Brooks and Eckerd at the Brooks headquarters located in Warwick, Rhode Island, leading to the closure of Eckerd's former Florida headquarters. However, between 2005 and 2006, integrating the Brooks and Eckerd chains proved challenging for Coutu. These difficulties contributed to a notable decline in market share for both Brooks and Eckerd stores under Coutu’s management.

Acquisition by Rite Aid

In August 2006, Rite Aid revealed plans to purchase Jean Coutu's American division, which included the Eckerd and Brooks chains, for $2.55 billion. This transaction encompassed 1,854 retail locations and six distribution centers, positioning Rite Aid as the foremost drugstore chain along the East Coast. By 2007, Rite Aid expanded further by acquiring 31 Brooks outlets in Vermont. Subsequently, all Brooks and Eckerd stores were either converted to the Rite Aid brand, sold off, or permanently closed, with the intended Rhode Island headquarters project being discontinued.

Despite divestiture by PJC in 2007, the entity known as The Jean Coutu Group (PJC) USA, Inc. continued to exist as a nominal subsidiary under Rite Aid's ownership, alongside Eckerd Corporation. This status was confirmed in Eckerd's Chapter 11 bankruptcy documentation filed in October 2023.

On May 5, 2025, Rite Aid initiated Chapter 11 bankruptcy proceedings for the second occasion within two years, reporting assets and liabilities ranging between $1 billion and $10 billion. As part of its restructuring efforts amid financial pressures such as mounting debt, intensified market competition, and inflationary impacts, Rite Aid announced plans to liquidate all assets, including those related to Brooks Pharmacy.